Concomitant loss of VHL and either PBRM1 or BAP1, two frequently mutated ccRCC genes3,14 could thus directly lead to increased mTORC1 activity during ccRCC development. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.